# Otolaryngology (head and neck surgery) Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jim Thorpe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML011-SYN-TD
- Date: 1951-06-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucia Ferrante, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Nolan Fairbanks, MD

## Reason for consultation

Suspected squamous cell carcinoma of the left lower lip in a 63-year-old former athlete with decades of outdoor work and about 35 pack-years of smoking, who also has chronic coronary disease with stable angina eight years after a heart attack. An incisional biopsy was taken on the day of this referral. Please confirm the diagnosis and stage, advise on treatment and the neck, advise on surgery with his heart disease and new aspirin, and set the surveillance plan. **S**

## History

Mr. Thorpe, a 63-year-old coach and speaker, is seen at the request of Dr. Fairbanks one week after an incisional biopsy of a lower lip sore present for about three months. He has worked outdoors for most of his life and smoked until eight years ago. He has no lip numbness, mouth pain, trouble swallowing, or neck lumps. He has stable exertional angina and started aspirin, atorvastatin and metoprolol a week ago. He wants to know how the operation will affect the look and use of his lip and whether he can keep coaching. **S**

## Examination

| System | Finding |
|---|---|
| Lips and mouth | 1.2 cm crusted, indurated ulcer of the left lower lip vermilion, 8 mm from the commissure, mobile over the deeper tissues; actinic change of both lips; lip sensation normal; oral cavity and tongue normal |
| Neck | No palpable lymph nodes in the submental, submandibular, or cervical regions |
| General | Well; blood pressure 130/80, pulse 64 |

BP 130/80 mmHg; pulse 64 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 93.8 kg; BMI 27.4 kg/m². All vital signs are synthetic.

## Data reviewed

Biopsy: invasive, well-differentiated keratinizing squamous cell carcinoma. Dr. Fairbanks's intake note. Echocardiogram this morning: left ventricular ejection fraction 55%, old inferior wall motion abnormality, no significant valve disease. Resting ECG: sinus rhythm with old inferior Q waves. Hemoglobin 14.8 g/dL, platelets 231 x10^3/uL, creatinine 1.02 mg/dL. Left ventricular ejection fraction (echocardiogram): 55%. All results are synthetic.

## Assessment

1. **Squamous cell carcinoma of the left lower lip** (C00.1). Invasive squamous cell carcinoma of the lower lip, 1.2 cm, with no palpable nodes: clinical T1 N0 (AJCC 8th edition, lip and oral cavity). Surgery is the preferred treatment. A V-excision with 5 to 10 mm clinical margins and frozen-section control of the margins, closed directly, removes up to a third of the lower lip with good function and appearance. Lower lip cancers of this size rarely spread to the neck; a contrast CT of the neck is reasonable before surgery to stage it, and elective neck dissection is not needed if the final depth of invasion is small, generally under 4 mm, with clear margins. Radiation is an alternative but is not preferred for a small, resectable lesion. **S**
2. **Chronic coronary disease with stable angina** (I25.119). An excision under local anesthesia is a low-risk operation. With stable angina, an ejection fraction of 55%, and no heart failure, no further cardiac testing is needed. Aspirin should be continued because bleeding from a lip excision is easily controlled, and metoprolol should not be stopped. **S**

## Recommendations

1. Contrast CT of the neck before surgery.
2. V-excision of the lower lip cancer under local anesthesia with 5 to 10 mm margins and frozen-section margin control, with primary closure, in about two weeks.
3. No elective neck dissection if the final depth of invasion is small and the margins are clear; re-excision if a margin is involved.
4. Continue aspirin 81 mg and metoprolol through surgery; acetaminophen for pain afterwards.
5. Surveillance by history and examination of the lips, mouth and neck every 1 to 3 months in the first year, every 2 to 6 months in the second, every 4 to 8 months in years 3 to 5, then yearly; imaging only for symptoms or findings.
6. Daily lip balm with sunscreen and a hat, yearly skin examination, staying tobacco-free, and a dental check-up.
7. Lung cancer screening with low-dose CT if he is eligible, because of his smoking history.

## Strengths and supports

- Strengths and supports: lifelong athlete who still walks and throws a ball with the young people he coaches; speaks about education and opportunity for Native youth; proud of his family and community **S**

## Communication

Discussed with Dr. Fairbanks, who sees him the same day. Mr. Thorpe asked many questions; the operation, the expected scar and lip function, and his return to coaching within about a week were explained, and he agreed to the plan. He decides who else receives this note. **S**

## Follow-up

Surgery in about two weeks; post-operative check by the surgical team at one week for suture removal; pathology reviewed with Dr. Fairbanks at two weeks; surveillance shared with Dr. Fairbanks. **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026), National Comprehensive Cancer Network
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology (Circulation)
- 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery (2024), American Heart Association and American College of Cardiology (Circulation)
- Skin Cancer Prevention: Behavioral Counseling (2018), U.S. Preventive Services Task Force
- Lung Cancer: Screening (2021), U.S. Preventive Services Task Force
